Mirae Asset Global Etfs Holdings Ltd. Hille Vax, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $43.4 Billion
- Q1 2025
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Hille Vax, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 19,260 shares of HLVX stock, worth $37,749. This represents 0.0% of its overall portfolio holdings.
Number of Shares
19,260
Previous 18,480
4.22%
Holding current value
$37,749
Previous $37,000
27.03%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding HLVX
# of Institutions
80Shares Held
34.9MCall Options Held
0Put Options Held
0-
Frazier Life Sciences Management, L.P. Menlo Park, CA10.6MShares$20.8 Million0.97% of portfolio
-
Tang Capital Management LLC San Diego, CA4.92MShares$9.64 Million0.46% of portfolio
-
Black Rock Inc. New York, NY2.09MShares$4.1 Million0.0% of portfolio
-
Franklin Resources Inc San Mateo, CA1.96MShares$3.84 Million0.0% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY1.88MShares$3.69 Million0.07% of portfolio
About HilleVax, Inc.
- Ticker HLVX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 33,427,200
- Market Cap $65.5M
- Description
- HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. It is developing HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company is headquartered in Boston, Massachusetts.